FESC Consortium was funded by the HRSA Office of Rural Health
Policy under three consecutive one-year cooperative agreements.
The current cooperative agreement is funded through August 31, 2007.
As the lead agency, SouthEast Alaska Regional Health Consortium
(SEARHC) has subcontracted with Iliuliuk Family and Health Services,
Cross Road Medical Center, and Inter Island Medical Center to fund
actual demonstration sites for the FESC model. Besides acting as
the lead agency for the FESC Consortium, SEARHC manages two demonstration
sites in southeast Alaska; at the Alicia Roberts Medical Center
in Klawock, and the Haines Health Center. The Native Village of
Eyak is not actually testing the model, but is participating in
the planning and evaluation process. Each of the five demonstration
sites have increased their staffing and upgraded facilities and
equipment to meet the challenges of providing quality FESC services.
One Report to the Office of Rural Health Policy. (Adobe PDF)
Two Report to the Office of Rural Health Policy. (Adobe PDF)
presentation to the National Rural Health Association Annual Conference
in May 2006. (Adobe PDF)
Center for Rural Health, located at the University of Alaska
Anchorage, is conducting the evaluation of the project. The evaluation
will assess the impact of FESC in four areas: staffing, services,
clinical outcomes, and financial.
Preliminary financial models were developed by
and David Mather and Associates. Their analyses on the first year
of data collected, in PowerPoint format, are included below:
The Alaska FESC Consortium Provider Workgroup,
composed of doctors, nurses, physician assistants, community health
aides, and other health care providers who are experienced at providing
FESC services is responsible for the following activities:
- Create FESC Vision
- Define Minimum Standards
- Guide Evaluation Process
- Discuss Quality of Care
- Describe Scope of Practice
- Identify Hazards/Risks/Criticisms
The Alaska FESC Consortium Steering Committee,
composed of one administrative and one clinical representative from
each site, meets monthly by teleconference and quarterly in a face-to-face
meeting. The Steering Committee provides oversight and direction
for the entire project.